Navigation Links
Stryker Corp. & Physiotherapy Associates to Pay U.S. $16.6 Million for Alleged False Claims to Federal Health Care Programs
Date:11/14/2007

WASHINGTON, Nov. 14 /PRNewswire-USNewswire/ -- Kalamazoo, Mich.-based Stryker Corporation and its former outpatient therapy division, Physiotherapy Associates Inc., have agreed to pay the United States $16.6 million to settle allegations that Physiotherapy submitted false claims to Medicare and other federal health care programs, the Justice Department announced today.

The settlement resolves allegations that Physiotherapy, which is based in Memphis, Tenn., submitted claims for services to Medicare, state Medicaid programs, and the Department of Defense's TRICARE program that were falsely billed as one-on-one services and that Physiotherapy improperly retained excess or duplicate payments it received from federal health care programs. Under the terms of the settlement, Physiotherapy agreed also to enter into a corporate integrity agreement with the Office of Inspector General for the Department of Health and Human Services.

"Submitting false claims to our nation's health care programs is tantamount to stealing from the American taxpayer," said Peter D. Keisler, Assistant Attorney General for the Civil Division. "Today's settlement sends a strong signal that the government aggressively pursues those who engage in such conduct and makes them pay a steep price for their misdeeds."

The settlement resulted from two qui tams, or whistleblower suits, filed by private citizens against Stryker and Physiotherapy. Both of the whistleblowers, Kerry Deering and Wendy Whitcomb, were employees of Physiotherapy. As a result of today's settlement, the two will receive nearly $3 million. Under the whistleblower provisions of the False Claims Act, private parties can file an action on behalf of the United States and receive a portion of the proceeds of a settlement or judgment awarded against a defendant.

"This settlement is a reflection of our office's commitment to protecting the integrity of the Medicare system," said Michael J. Sullivan, U.S. Attorney for the District of Massachusetts. "The conduct in this case, which included billing for services not covered, and retaining overpayments from federal healthcare programs, is unacceptable."

"This case underscores the commitment of this office to vigorously investigate and prosecute qui tam suits, said David F. Kustoff, U.S. Attorney for the Western District of Tennessee. "The amount paid to settle this litigation should serve as a deterrent to other health care providers who seek to defraud federal health care programs."

The resolution of these two cases was achieved by the Justice Department's Civil Division, Commercial Litigation Branch, and the U.S. Attorney's Offices for the District of Massachusetts and the Western District of Tennessee.


'/>"/>
SOURCE U.S. Department of Justice
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Stryker To Host Conference Call on October 17, 2007
2. Stryker to Present at Investor Conference
3. Stryker Announces Resolution Related to March 2005 U.S. Department of Justice Subpoena
4. Stryker Discloses Informal Inquiry Made by United States Securities and Exchange Commission
5. Stryker to Present at Investor Conferences
6. Stryker to Present at Investor Conference
7. Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market
8. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
9. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
10. Drug Detection Kits Manufactured By IDenta Corp. Shown During French Television Broadcast (at TF1) - Product Aids French Police In Bust of 600 Kilograms Of Cocaine
11. ComPsych(R) Corp. Announces Health at Work(SM) Award Winners: Sprint, Erie Insurance, City of Naperville and Green Hills Public Library
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Intermedix ... of Emergency Medicine , an emergency medicine professional association, to support the organization's ... , The American Academy of Emergency Medicine, or AAEM, seeks to empower emergency ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Emergency rooms provide ... to find. Unfortunately, this can leave patients with dental emergencies at risk of losing ... now offering emergency dental care. , Common dental emergencies include:, ...
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. Jessica Barron, of ... is now accepting new dental patients and families in the North Metro Denver area. ... services from cleanings to cosmetic dentistry, and all in the most relaxing environment. , ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... organization, welcomes S.S. Nesbitt as the latest addition to its growing list of ... other locations throughout the Southeast, from Orlando to Huntsville and in between. , ...
(Date:2/10/2016)... ... , ... Armune BioScience signed a definitive agreement with ARCpoint ... across the country. Launched in April of 2015, Apifiny is the only cancer specific, ... order volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... LONDON , February 10, 2016 A new report ... 2021 - states that the Alzheimer,s disease market will more than double ... 2021, at a Compound Annual Growth Rate (CAGR) of 11%. ... Italy , Spain , the UK, and ... prevalence during the forecast period. --> Canada , ...
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... viral gene therapy manufacturing, and Renova™ Therapeutics, a biopharmaceutical ... and other chronic diseases, have entered into a Manufacturing ... produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for use in ... --> This relationship will leverage Lonza,s ...
(Date:2/10/2016)... , Feb. 10, 2016 Immune Pharmaceuticals Inc. ... announced today that it has filed a patent application ... other cancers. --> --> ... by administration of Ceplene (histamine dihydrochloride) in combination with ... of predicting the efficacy of Ceplene and IL-2 therapy ...
Breaking Medicine Technology: